Multifunctional dressing for treatment of diabetic wounds

治疗糖尿病伤口的多功能敷料

基本信息

项目摘要

PROJECT SUMMARY Chronic diabetic wounds (CDW) are one of the most challenging and common medical complications of type-2 diabetes. CDWs are associated with significantly increased costs for healthcare systems and society, decreased quality of life for patients, higher rates of co-morbidities such as recurrent infections and amputations, and an overall dramatically higher mortality rate. The wide prevalence of type-2 diabetes and its constantly increasing impact urgently demand the need for effective treatments aimed at restoring physiological healing of CDWs and preventing associated co-morbidities and mortality. Insufficient skin vascularization and infection inhibit effective healing of CDWs. In non-diabetic injuries, physiologic healing relies on neoangiogenesis and vascularization to restore tissue oxygenation, provide metabolic support to regenerating cells/tissues, and to allow migration of immune cells to counteract pathogens. Instead, in CDWs angiogenesis is impaired resulting in tissue hypoxia, lack of the metabolic support required for tissue repair, and an insufficient immune-response to bacterial infections. These conditions first “lock” CDWs in a chronic inflammatory state unable to progress to tissue repair and second place the patients at risk of sepsis. In severe cases, surgical debridement or limb amputation is the only option for saving patients’ lives. Our hypothesis is that the delivery of VEGF (an angiogenic factor), oxygen combined with on demand release of antibiotics in response to upregulation of neutrophil secretomes can prevent biofilm formation and in turn can reduce the CDW morbidity rate. The goal of this proposal is to engineer bandages containing microneedle arrays that can control release VEGF, oxygen, and can self respond to upregulation of bacteria mediated neutrophil secretomes for inducing healing and avoiding infection.
项目总结 慢性糖尿病创面是2型糖尿病最具挑战性和最常见的内科并发症之一。 糖尿病。CDW与显著增加的医疗系统和社会成本相关, 患者生活质量下降,反复感染等共病发生率上升, 截肢,以及总体上极高的死亡率。2型糖尿病的广泛流行及其原因 不断增加的影响迫切需要旨在恢复 CDW的生理愈合和预防相关的合并症和死亡率。皮肤不足 血管化和感染抑制了CDW的有效愈合。在非糖尿病损伤中,生理性愈合 依靠新生血管生成和血管形成来恢复组织氧合,为 再生细胞/组织,并允许免疫细胞迁移以对抗病原体。相反,在CDW中 血管生成受损,导致组织缺氧,缺乏组织修复所需的代谢支持, 对细菌感染的免疫反应不足。这些情况首先将CDW锁定在慢性疾病中 炎症状态不能进展到组织修复,其次是有脓毒症风险的患者。严重者 在某些情况下,外科清创或截肢是挽救病人生命的唯一选择。我们的假设是 血管内皮生长因子(一种血管生成因子)的输送,氧气和抗生素的按需释放在 对中性粒细胞分泌体上调的反应可以防止生物被膜的形成,进而可以减少 CDW患病率。该方案的目标是设计包含微针阵列的绷带 可以控制血管内皮生长因子、氧气的释放,并能对细菌介导的上调做出自我反应 促进愈合和避免感染的中性粒细胞分泌物。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Microneedle arrays for the treatment of chronic wounds.
  • DOI:
    10.1080/17425247.2020.1819787
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    6.6
  • 作者:
    Barnum L;Samandari M;Schmidt TA;Tamayol A
  • 通讯作者:
    Tamayol A
Fibrous Systems as Potential Solutions for Tendon and Ligament Repair, Healing, and Regeneration.
  • DOI:
    10.1002/adhm.202001305
  • 发表时间:
    2021-04
  • 期刊:
  • 影响因子:
    10
  • 作者:
    Rinoldi C;Kijeńska-Gawrońska E;Khademhosseini A;Tamayol A;Swieszkowski W
  • 通讯作者:
    Swieszkowski W
In situ forming microporous gelatin methacryloyl hydrogel scaffolds from thermostable microgels for tissue engineering.
  • DOI:
    10.1002/btm2.10180
  • 发表时间:
    2020-09
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Zoratto N;Di Lisa D;de Rutte J;Sakib MN;Alves E Silva AR;Tamayol A;Di Carlo D;Khademhosseini A;Sheikhi A
  • 通讯作者:
    Sheikhi A
A Breathable, Passive-Cooling, Non-Inflammatory, and Biodegradable Aerogel Electronic Skin for Wearable Physical-Electrophysiological-Chemical Analysis.
一种透气、被动冷却、非炎症且可生物降解的气凝胶电子皮肤,用于可穿戴物理电生理化学分析。
  • DOI:
    10.1002/adma.202209300
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Zhu,Yangzhi;Haghniaz,Reihaneh;Hartel,MartinC;Guan,Shenghan;Bahari,Jamal;Li,Zijie;Baidya,Avijit;Cao,Ke;Gao,Xiaoxiang;Li,Jinghang;Wu,Zhuohong;Cheng,Xuanbing;Li,Bingbing;Emaminejad,Sam;Weiss,PaulS;Khademhosseini,Ali
  • 通讯作者:
    Khademhosseini,Ali
Smart Bandages: The Future of Wound Care.
聪明的绷带:伤口护理的未来。
  • DOI:
    10.1016/j.tibtech.2018.07.007
  • 发表时间:
    2018-12
  • 期刊:
  • 影响因子:
    17.3
  • 作者:
    Derakhshandeh H;Kashaf SS;Aghabaglou F;Ghanavati IO;Tamayol A
  • 通讯作者:
    Tamayol A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mehmet Remzi Dokmeci其他文献

Deciphering pericyte-induced temozolomide resistance in glioblastoma with a 3D microphysiological system mimicking the biomechanical properties of brain tissue
利用模拟脑组织生物力学特性的三维微生理系统破译胶质母细胞瘤中周细胞诱导的替莫唑胺耐药性
  • DOI:
    10.1016/j.actbio.2025.05.038
  • 发表时间:
    2025-06-15
  • 期刊:
  • 影响因子:
    9.600
  • 作者:
    Surjendu Maity;Christopher Jewell;Can Yilgor;Satoru Kawakita;Saurabh Sharma;Alejandro Gomez;Marvin Mecwan;Natashya Falcone;Menekse Ermis;Mahsa Monirizad;Negar Hosseinzadeh Kouchehbaghi;Fatemeh Zehtabi;Danial Khorsandi;Mehmet Remzi Dokmeci;Diogo Moniz-Garcia;Alfredo Quiñones-Hinojosa;Ali Khademhosseini;Vadim Jucaud
  • 通讯作者:
    Vadim Jucaud

Mehmet Remzi Dokmeci的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mehmet Remzi Dokmeci', 18)}}的其他基金

3D printed muscle-bone organ implant for treating large injuries
3D打印肌肉骨骼器官植入物用于治疗大面积损伤
  • 批准号:
    10305697
  • 财政年份:
    2020
  • 资助金额:
    $ 31.56万
  • 项目类别:
3D printed muscle-bone organ implant for treating large injuries
3D打印肌肉骨骼器官植入物用于治疗大面积损伤
  • 批准号:
    10393059
  • 财政年份:
    2020
  • 资助金额:
    $ 31.56万
  • 项目类别:
Cardiotoxicity Assays on an Integrated Platform of a Heart-on-a-Chip and an Optical Immunosensor
芯片心脏和光学免疫传感器集成平台的心脏毒性测定
  • 批准号:
    10249004
  • 财政年份:
    2018
  • 资助金额:
    $ 31.56万
  • 项目类别:
Research Supplements to Promote Diversity
促进多样性的研究补充
  • 批准号:
    10281488
  • 财政年份:
    2018
  • 资助金额:
    $ 31.56万
  • 项目类别:
Cardiotoxicity Assays on an Integrated Platform of a Heart-on-a-Chip and an Optical Immunosensor
芯片心脏和光学免疫传感器集成平台的心脏毒性测定
  • 批准号:
    10472876
  • 财政年份:
    2018
  • 资助金额:
    $ 31.56万
  • 项目类别:
Cardiotoxicity Assays on an Integrated Platform of a Heart-on-a-Chip and an Optical Immunosensor
芯片心脏和光学免疫传感器集成平台的心脏毒性测定
  • 批准号:
    10265584
  • 财政年份:
    2018
  • 资助金额:
    $ 31.56万
  • 项目类别:
Multifunctional dressing for treatment of diabetic wounds
治疗糖尿病伤口的多功能敷料
  • 批准号:
    10136899
  • 财政年份:
    2018
  • 资助金额:
    $ 31.56万
  • 项目类别:

相似海外基金

How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
  • 批准号:
    22KJ0818
  • 财政年份:
    2023
  • 资助金额:
    $ 31.56万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10711027
  • 财政年份:
    2021
  • 资助金额:
    $ 31.56万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10297199
  • 财政年份:
    2021
  • 资助金额:
    $ 31.56万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10625314
  • 财政年份:
    2021
  • 资助金额:
    $ 31.56万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10405070
  • 财政年份:
    2021
  • 资助金额:
    $ 31.56万
  • 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
  • 批准号:
    20K06385
  • 财政年份:
    2020
  • 资助金额:
    $ 31.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
  • 批准号:
    17K11866
  • 财政年份:
    2017
  • 资助金额:
    $ 31.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
  • 批准号:
    15K20874
  • 财政年份:
    2015
  • 资助金额:
    $ 31.56万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
  • 批准号:
    15K15523
  • 财政年份:
    2015
  • 资助金额:
    $ 31.56万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
  • 批准号:
    26860367
  • 财政年份:
    2014
  • 资助金额:
    $ 31.56万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了